The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care
Open accessAbstract
An accurate diagnosis is an integral component of patient care for children with rare genetic disease. Recent advances in sequencing, in particular whole‐exome sequencing (WES), are identifying the genetic basis of disease for 25–40% of patients. The diagnostic rate is probably influenced by when in the diagnostic process WES is used. The Finding Of Rare Disease GEnes (FORGE) Canada project was a nation‐wide effort to identify mutations for childhood‐onset disorders using WES. Most children enrolled in the FORGE project were toward the end of the diagnostic odyssey. The two primary outcomes of FORGE were novel gene discovery and the identification of mutations in genes known to cause disease. In the latter instance, WES identified mutations in known disease genes for 105 of 362 families studied (29%), thereby informing the impact of WES in the setting of the diagnostic odyssey. Our analysis of this dataset showed that these known disease genes were not identified prior to WES enrollment for two key reasons: genetic heterogeneity associated with a clinical diagnosis and atypical presentation of known, clinically recognized diseases. What is becoming increasingly clear is that WES will be paradigm altering for patients and families with rare genetic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306555 · Cited by 1,964
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360
Genome sequencing identifies major causes of severe intellectual disability
Gilissen, C., Hehir-Kwa, J. Y., Thung, D. T., van de Vorst, M., van Bon, B. W. M., Willemsen, M. H., Kwint, M., Janssen, I. M., Hoischen, A., Schenck, A., et al. (2014) · Nature · doi:10.1038/nature13394 · Cited by 1,125
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
The human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034
Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders
Lee, H., Deignan, J. L., Dorrani, N., Strom, S. P., Kantarci, S., Quintero-Rivera, F., Das, K., Toy, T., Harry, B., Yourshaw, M., et al. (2014) · JAMA · doi:10.1001/jama.2014.14604 · Cited by 973
A de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852
Rare-disease genetics in the era of next-generation sequencing: discovery to translation
Boycott, K. M., Vanstone, M. R., Bulman, D. E., & MacKenzie, A. E. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3555 · Cited by 763
Self-citationMendelian Inheritance in Man and Its Online Version, OMIM
McKusick, V. A. (2007) · The American Journal of Human Genetics · doi:10.1086/514346 · Cited by 739
Diagnostic Clinical Genome and Exome Sequencing
Biesecker, L. G., & Green, R. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312543 · Cited by 607
Diagnostic Clinical Genome and Exome Sequencing
(2014) · New England Journal of Medicine · doi:10.1056/nejmc1408914 · Cited by 530
Soden, S. E., Saunders, C. J., Willig, L. K., Farrow, E. G., Smith, L. D., Petrikin, J. E., LePichon, J.-B., Miller, N. A., Thiffault, I., Dinwiddie, D. L., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010076 · Cited by 528
Clinical application of exome sequencing in undiagnosed genetic conditions
Need, A. C., Shashi, V., Hitomi, Y., Schoch, K., Shianna, K. V., McDonald, M. T., Meisler, M. H., & Goldstein, D. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100819 · Cited by 438
Whole-genome sequencing in health care: Recommendations of the European Society of Human Genetics
on behalf of the ESHG Public and Professional Policy Committee, van El, C. G., Cornel, M. C., Borry, P., Hastings, R. J., Fellmann, F., Hodgson, S. V., Howard, H. C., Cambon-Thomsen, A., Knoppers, B. M., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.46 · Cited by 387
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.
van El, C. G., Cornel, M. C., Borry, P., Hastings, R. J., Fellmann, F., Hodgson, S. V., Howard, H. C., Cambon‐Thomsen, A., Knoppers, B. M., Meijers-Heijboer, H. E. J., et al. (2013) · Europe PMC (PubMed Central) · Cited by 361
Neveling, K., Feenstra, I., Gilissen, C., Hoefsloot, L. H., Kamsteeg, E.-J., Mensenkamp, A. R., Rodenburg, R. J. T., Yntema, H. G., Spruijt, L., Vermeer, S., et al. (2013) · Human Mutation · doi:10.1002/humu.22450 · Cited by 331
Shashi, V., McConkie-Rosell, A., Rosell, B., Schoch, K., Vellore, K., McDonald, M., Jiang, Y.-H., Xie, P., Need, A., & Goldstein, D. B. (2014) · Genetics in Medicine · doi:10.1038/gim.2013.99 · Cited by 290
Exome Sequencing Can Improve Diagnosis and Alter Patient Management
Dixon-Salazar, T. J., Silhavy, J. L., Udpa, N., Schroth, J., Bielas, S., Schaffer, A. E., Olvera, J., Bafna, V., Zaki, M. S., Abdel-Salam, G. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003544 · Cited by 258
Graungaard, A. H., & Skov, L. (2007) · Child: Care, Health and Development · doi:10.1111/j.1365-2214.2006.00666.x · Cited by 258
PhenoTips: Patient Phenotyping Software for Clinical and Research Use
Girdea, M., Dumitriu, S., Fiume, M., Bowdin, S., Boycott, K. M., Chénier, S., Chitayat, D., Faghfoury, H., Meyn, M. S., Ray, P. N., et al. (2013) · Human Mutation · doi:10.1002/humu.22347 · Cited by 249
Self-citationPoints to consider in the clinical application of genomic sequencing
(2012) · Genetics in Medicine · doi:10.1038/gim.2012.74 · Cited by 249
FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project
Beaulieu, C. L., Majewski, J., Schwartzentruber, J., Samuels, M. E., Fernandez, B. A., Bernier, F. P., Brudno, M., Knoppers, B., Marcadier, J., Dyment, D., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.003 · Cited by 239
Self-citationBoycott, K., Hartley, T., Adam, S., Bernier, F., Chong, K., Fernandez, B. A., Friedman, J. M., Geraghty, M. T., Hume, S., Knoppers, B. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103144 · Cited by 237
Self-citationBragin, E., Chatzimichali, E. A., Wright, C. F., Hurles, M. E., Firth, H. V., Bevan, A. P., & Swaminathan, G. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt937 · Cited by 233
Lines, M. A., Huang, L., Schwartzentruber, J., Douglas, S. L., Lynch, D. C., Beaulieu, C., Guion-Almeida, M. L., Zechi-Ceide, R. M., Gener, B., Gillessen-Kaesbach, G., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.023 · Cited by 215
Self-citationSobreira, N., Schiettecatte, F., Boehm, C., Valle, D., & Hamosh, A. (2015) · Human Mutation · doi:10.1002/humu.22769 · Cited by 170
Grapp, M., Just, I. A., Linnankivi, T., et al. (2012) · Brain · doi:10.1093/brain/aws122 · Cited by 130
Exome Sequencing as a Diagnostic Tool for Pediatric‐Onset Ataxia
Sawyer, S. L., Schwartzentruber, J., Beaulieu, C. L., Dyment, D. A., Smith, A. C., Warman‐Chardon, J., Yoon, G., Rouleau, G. A., Suchowersky, O., Siu, V. M., et al. (2013) · Human Mutation · doi:10.1002/humu.22451 · Cited by 100
Self-citationDyment, D. A., Tétreault, M., Beaulieu, C. L., Hartley, T., Ferreira, P. C., Warman‐Chardon, J., Marcadier, J., Sawyer, S. L., Mosca, S. J., Innes, A. M., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12464 · Cited by 95
Self-citationMutations in TMEM231 cause Joubert syndrome in French Canadians
Srour, M., Hamdan, F. F., Schwartzentruber, J., Patry, L., Ospina, L. H., Shevell, M. I., Désilets, V. A., Dobrzeniecka, S., Mathonnet, G., Lemyre, E., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101132 · Cited by 73
Self-citationFernandez, B. A., Green, J. S., Bursey, F. R., Barrett, B. J., MacMillan, A., McColl, S., Fernandez, S., Rahman, P., Mahoney, K., Pereira, S. L., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-111 · Cited by 25
Self-citationAtypical fibrodysplasia ossificans progressiva diagnosed by whole‐exome sequencing
Liu, H., Sawyer, S. L., Goś, M., Grynspan, D., Issa, K., Ramphal, R., Rotaru, C., Majewski, J., Boycott, K. M., Graham, G. E., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36969 · Cited by 11
Self-citation
Cited by
Clark, M. M., Stark, Z., Farnaes, L., Tan, T. Y., White, S. M., Dimmock, D., & Kingsmore, S. F. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0053-8 · Cited by 619
Manickam, K., McClain, M. R., Demmer, L. A., Biswas, S., Kearney, H. M., Malinowski, J., Massingham, L. J., Miller, D., Yu, T. W., & Hisama, F. M. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01242-6 · Cited by 639
Schwarze, K., Buchanan, J., Taylor, J. C., & Wordsworth, S. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.247 · Cited by 513
Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
Stark, Z., Tan, T. Y., Chong, B., Brett, G. R., Yap, P., Walsh, M., Yeung, A., Peters, H., Mordaunt, D., Cowie, S., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.1 · Cited by 396
Metadata
- Authors
- Sawyer, S. L., Hartley, T., Dyment, D. A., Beaulieu, C. L., Schwartzentruber, J., Smith, A., Bedford, H. M., Bernard, G., Bernier, F. P., Brais, B., Bulman, D. E., Warman Chardon, J., Chitayat, D., Deladoëy, J., Fernandez, B. A., Frosk, P., Geraghty, M. T., Gerull, B., Gibson, W., Gow, R. M., Graham, G. E., Green, J. S., Heon, E., Horvath, G., Innes, A. M., Jabado, N., Kim, R. H., Koenekoop, R. K., Khan, A., Lehmann, O. J., Mendoza‐Londono, R., Michaud, J. L., Nikkel, S. M., Penney, L. S., Polychronakos, C., Richer, J., Rouleau, G. A., Samuels, M. E., Siu, V. M., Suchowersky, O., Tarnopolsky, M. A., Yoon, G., Zahir, F. R., FORGE Canada Consortium, Care4Rare Canada Consortium, Majewski, J., & Boycott, K. M.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2015-09-22
- Volume
- 89
- Issue
- 3
- Pages
- 275-284
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2165800754
- Cited by
- 383
- References
- 34
- FWCI
- 27.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.